刘若年

Engineering bacterial nanosyringes for regional immune recalibration at the oral barrier

Wan AH, Liang H, Yan S, Xiao M, Liu R, Wan G*

Oral Sci Homeost Med. 2026 May; 2(2): 9610055.·2026·DOI

Dual-system engineered bacteria and dendritic cells enable precise intratumoral IL-12 delivery and potent antitumor immunity.

Deng Y#, Liang H#, Wan AH#, Liu C#, Yan S#, Li J, Xiao M, Zhou Q, Liu R, Zhang Z, Zhang H, Cheng H, Fu C, Yao Q, Fang J, Neumann S, Wang Q, Huang J*, Wang Z*, Wan G*.

Cell Rep Med. 2026 Jun 16;7(6):102801.·2026·DOI

HNRNPA2B1 Orchestrates Immune Evasion in Colorectal Cancer by Rewiring Tumor-Immune Cell Interactions and Suppressing CD8+ T-cell Infiltration.

Liu C, Liang H, Wang P, Xiao M, Zheng Y, Yan S, Deng Y, Liu R, Wan AH, Wang Z*, Lu X*, Song W*, He W*, Wan G*.

Cancer Immunol Res. 2026 Jan 8;14(1):60-76.·2026·DOI

Decoding the m6A epitranscriptomic landscape for biotechnological applications using a direct RNA sequencing approach.

Liu C#, Liang H#, Wan AH#, Xiao M#, Sun L#, Yu Y, Yan S, Deng Y, Liu R, Fang J, Wang Z*, He W*, Wan G*.

Nat Commun. 2025 Jan 18;16(1):798.·2025·DOI

A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance.

Sun L, Wan AH, Yan S, Liu R, Li J, Zhou Z, Wu R, Chen D, Bu X, Ou J, Li K, Lu X, Wan G*, Ke Z*.

Acta Pharm Sin B. 2024 Jan;14(1):223-240.·2024·DOI

Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer.

Sun L, Liu R, Wu ZJ, Liu ZY, Wan AH, Yan S, Liu C, Liang H, Xiao M, You N, Lou Y, Deng Y, Bu X, Chen D, Huang J, Zhang X, Kuang DM, Wan G*.

Gastroenterology. 2024 Mar;166(3):466-482.·2024·DOI